Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06466447 · ClinicalTrials.gov registry record
Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment
A clinical trial, sponsored by NOCD.
- Completed
- Registry status
- 2,173
- Enrollment target
NCT06466447: Completed study, sponsored by NOCD.
NCT06466447 is a clinical trial that has completed, run by NOCD. The registered enrollment target is 2,173 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06466447 has completed, sponsored by NOCD.
- COMPLETED
- Registry status
- 2,173 participants
- Enrollment target
Study Summary
This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.
Primary Outcome
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes (score range: 0-80)
Interventions
- BEHAVIORAL Exposure and response prevention therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,173 participants |
| Start Date | 2020-07-23 |
| Est. Completion | 2024-05-03 |
What the finished NCT06466447 record still lists
NCT06466447 is an observational study that tracks outcomes without assigning an intervention. Its 2,173 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Exposure and response prevention therapy is the first listed.
NCT06466447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06466447 about?
NCT06466447 is a clinical study titled "Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment". This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.
What is the current status of trial NCT06466447?
This trial is currently completed. The enrollment target is 2,173 participants. The study started on 2020-07-23. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT06466447?
The interventions under investigation include: Exposure and response prevention therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06466447?
This trial is sponsored by NOCD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI